Home
Recordati Rare Diseases

Recordati Rare Diseases Market Share Analysis for November 2025

We want to develop a group of like-minded, passionate individuals who go to extraordinary lengths for our stakeholders across the globe.

Health > Biotechnology and Pharmaceuticals

Domainrecordatirarediseases.com

Year Founded1990

Employees201 - 500

Annual Revenue--

Recordati Rare Diseases

Recordati Rare Diseases (including company regionals)

recordatirarediseases.com

See more website traffic and engagement information

Total visits to Recordati Rare Diseases's top domains

Understand Recordati Rare Diseases market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

recordatirarediseases.com3.5K

See more with Sales Intelligence

Avg. visit duration in Recordati Rare Diseases's top domains

Analyze Recordati Rare Diseases engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

recordatirarediseases.com00:05:49

See more with Sales Intelligence

Avg. pageviews on Recordati Rare Diseases's top domains

See how Recordati Rare Diseases keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

recordatirarediseases.com9.07

See more with Sales Intelligence

Recordati Rare Diseases top competitors by domain

Top similar sites in November 2025, ranked by their affinity

recordati.comCompany NameRECORDATIEmployees1001 - 5000HQItaly, MilanoAnnual revenue> $1BTotal visits60.3KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Recordati Rare Diseases

These are the website technologies, by industry, used by Recordati Rare Diseases top domains

Payment & Currencies (5)

PayPal

Content Management System (4)

WordPress

Conversion & Analytics (4)

Google Analytics

Widget (4)

Twemoji

More Technologies

9

See all

News & Signals from Recordati Rare Diseases

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsLida Audio Visual partnered with Recordati Rare Diseases Inc. on Mar 16th '25.Lida Audio Visual recently partnered with Recordati Rare Diseases to deliver a high-impact hybrid livestream at Panama Dining Room.

NewsSanofi SA sells assets to Recordati Rare Diseases Inc..Recordati has successfully acquired global rights to Enjaymo(R), a groundbreaking treatment for cold agglutinin disease, from Sanofi.

NewsRecordati Rare Diseases Inc. acquired Enjaymo on Oct 11th '24.Earlier this week, Italian pharmaceutical firm Recordati agreed to acquire Sanofi's biologic drug Enjaymo (sutimlimab) to expand its rare diseases portfolio.